About: The effect of COVID-19 pandemic on seizure control and self-reported stress on epilepsy patient

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The effect of COVID-19 pandemic on seizure control and self-reported stress on epilepsy patient Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The effect of COVID-19 pandemic on seizure control and self-reported stress on epilepsy patient
Creator	Alkhotani, Amal Almuntashri, Fahad Baothman, Renad Siddiqui, Muhammad
Source	Elsevier; Medline; PMC
abstract	Abstract Objectives To assess if patients with epilepsy (PWE) experienced an increase in seizure frequency and self-reported stress during the COVID-19 pandemic. Methods This is a cross-sectional study conducted in Saudi Arabia in April 2020. An electronic self-administered questionnaire was distributed to PWE via their treating neurologist. The variables included were demographic and baseline clinical characteristics (age, gender, living situation, occupational status, type of epilepsy, duration of epilepsy, number of antiepileptic medications (AEDs), presence of known psychiatric illness, and use of psychiatric medications), their seizure control in the month prior to the pandemic, perceived stress during this period of time, sleep changes, compliance changes, and change in seizure control during the pandemic. Results A total of 156 patients completed the questionnaire, with 29.5% reporting an increase in seizure frequency. Additionally, 59.4% reported an increase in self-reported stress and 71.2% experienced a significant change in their sleep during this period. Higher baseline seizure frequency, more AEDs, non-compliance, increase in self-reported stress, and sleep changes are the significant factors associated with increase in seizure frequency during the pandemic. Conclusion Identifying high-risk patients for seizure recurrence is important in order to provide them with adequate support to reduce such risk.
has issue date	2020-07-14(xsd:dateTime)
bibo:doi	10.1016/j.yebeh.2020.107323
bibo:pmid	32712565
has license	els-covid
sha1sum (hex)	3bb78707cde9d25132117b7dd8b00e5775993f8d
schema:url	https://doi.org/10.1016/j.yebeh.2020.107323
resource representing a document's title	The effect of COVID-19 pandemic on seizure control and self-reported stress on epilepsy patient
has PubMed Central identifier	PMC7359799
has PubMed identifier	32712565
schema:publication	Epilepsy Behav
resource representing a document's body	covid:3bb78707cde9d25132117b7dd8b00e5775993f8d#body_text
is schema:about of	named entity 'patient' named entity 'seizure' named entity 'World Health Organization' named entity 'epileptic attacks' named entity 'self-reported' named entity 'psychiatric illness' named entity 'seizures' named entity 'life-threatening' named entity 'Saudi Arabia' named entity 'IBM' named entity 'epilepsy' named entity 'Saudi Arabia' named entity 'quality of life' named entity 'sleep deprivation' named entity 'cover letter' named entity 'self-reported' named entity 'COVID-19' named entity 'control group' named entity 'focal epilepsy' named entity 'seizures' named entity 'collective efficacy' named entity 'March 23' named entity 'hygiene' named entity 'China' named entity 'non-compliance' named entity 'self-reported' named entity 'April 2020' named entity 'depression' named entity 'fatigue' named entity 'global pandemic' named entity 'psychological support' named entity 'epilepsy' named entity 'analysis of variance' named entity 'epilepsy' named entity 'Epilepsy' named entity 'virus' named entity 'p-value' named entity 'clinical treatment' named entity 'risk factors' named entity 'clinical characteristics' named entity 'Saudi Arabia' named entity 'psychological stress' named entity 'seizures' named entity 'seizures' named entity 'clinical characteristics' named entity 'drug resistant' named entity 'mental diseases' named entity 'mood disorder' named entity 'reduce the spread' named entity 'Wuhan' named entity 'neurological diseases' named entity 'risk factors' named entity 'demographic' named entity 'emergency room' named entity 'Arabic' named entity 'Arabic' named entity 'questionnaire' named entity 'COVID-19' named entity 'infection' named entity 'seizures' named entity 'self-reported' named entity 'Statistical significance' named entity 'sampling technique' named entity 'Italian' named entity 'emergency room' named entity 'epilepsy' named entity 'higher risk' named entity 'self-reported' named entity 'epilepsy' named entity 'epilepsy' named entity 'ANOVA' named entity 'neurologists' named entity 'epilepsy' named entity 'demographic' named entity 'self-reported' named entity 'COVID-19' named entity 'infectivity' named entity 'questionnaire'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software